Results 51 to 60 of about 5,907 (191)
Chinese Journal of Contemporary Neurology and Neurosurgery, 2014 Objective To evaluate the effect of Myozyme on one ventilator dependent patient with late-onset glycogen storage disease typeⅡ (GSDⅡ). Methods Myozyme infusion was administered based on manufacturer's recommendations at 20 mg/kg every 2 to 4 weeks ...
Juan YANG +10 more
doaj
Etude chimique d'un dépôt collant sur turbines "open end" [PDF]
, 1983 Les dépôts collants laissés par un coton d'Afrique de l'Ouest sur des turbines de filature "open end" ont été étudiés par analyse chimique: celle-ci montre l'origine essentiellement biologique du dépôt, la présence de sucres et de polyols, ainsi que de ...
Bonvalet, Annick +2 more
core
.ALPHA.-Glucosidase Inhibitors from Millettia conraui
Chemical and Pharmaceutical Bulletin, 2007 A new geranylated isoflavone, 7-O-geranyl-6-methoxypseudobaptigenin (1) was isolated from the stem barks of Millettia conraui, along with known compounds 5-methoxydurmillone (2), conrauinone A (3), beta-amyrine (4), sitosterol (5), 3-O-beta-D-glucopyranosyl sitosterol (6) and n-docosanol (7).
Alembert, Tiabou Tchinda +5 more
openaire +3 more sources
Natural Products as a Potential Enzyme Inhibitors from Medicinal Plants [PDF]
, 2017 Enzyme inhibitory agents are attractive because of their application in treating different ailments. The absence of enzymes produce a number of diseases.
Jehan, Noor, Rauf, Abdur
core +2 more sources
.ALPHA.-Glucosidase Inhibitor from Bergenia ligulata
Journal of Oleo Science, 2008 Inhibitory compound of alpha-glucosidase activity, (+)-afzelechin (1), was isolated from rhizomes of Bergenia ligulata. The structure was identified by IR, EI-MS, (1)H and (13)C NMR spectroscopy. The ID(50) (50% inhibition dose) value of compound 1 was 0.13 mM. To investigate the structure-activity relationship, (+)-afzelechin tetraacetate (2), (+)-5,7,
Junichi, Saijyo +5 more
openaire +3 more sources
Chinese Journal of Contemporary Neurology and Neurosurgery, 2014 Glycogen storage disease typeⅡ (GSDⅡ) is a rare progressive lysosomal storage disease caused by deficiency of acid α-glucosidase (GAA). The gene is located in 17q25.3. Diagnosis has been classically made by means of muscular biopsy.
Hong-zhi GUAN, Li-ying CUI
doaj
Complete Genome Sequencing of Lactobacillus plantarum UNQLp 11 Isolated from a Patagonian Pinot Noir Wine [PDF]
, 2020 Lactobacillus plantarum UNQLp 11 strain was isolated from a Patagonian Pinot noir wine at the oldest commercial winery (110 years old) in General Roca, North Patagonia, Argentina, and has demonstrated its ability to survive during winemaking processes ...
Bravo Ferrada, Barbara Mercedes +6 more
core +1 more source
Isolation And Characterization Of Natural Alpha-Glucosidase Inhibitors From Antioxidant Rich Red Wine Grapes (vitis Vinifera) [PDF]
, 2014 Background: Diabetes is currently a global public health problem affecting people at all ages. Dietary antioxidants have been associated with a reduced risk of type 2 diabetes.
Kadouh, Hoda Chaouki
core +1 more source
DEVELOPMENT OF HERBAL CAPSULES CONTAINING MULBERRY LEAF AND BLACK TEA EXTRACTS USING THE MODIFIED LIQUISOLID TECHNIQUES [PDF]
, 2019 Objective: The objective of this study was to develop the capsules containing mulberry leaf extract (MLE) and black tea extract (BTE). Methods: MLE and BTE were prepared by maceration and determined for phytochemicals, in vitro alpha-amylase and alpha ...
Jaipakdee, Napaphak +2 more
core +3 more sources
Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase [PDF]
, 1998 The existence of a non-lysosomal glucosylceramidase in human cells has been documented (van Weely, S., Brandsma, M., Strijland, A., Tager, J. M., and Aerts, J. M. F. G. (1993) Biochim. Biophys. Acta 1181, 55-62).
Aerts, J.M.F.G. +9 more
core +4 more sources